The environment shapes your cravings ...

We talk a lot about willpower.

We talk about discipline, about making better choices, about getting back on track. We hand people meal plans and supplement protocols, breathing exercises, and stress management strategies. And THEN we watch them struggle — not because they aren’t trying, but because something upstream is working against them.

That something has a name: the appetitive state.

In neuroscience, the appetitive state describes the brain’s motivational drive toward reward-seeking behavior. It is the neurological engine of wanting — the restless, relentless pull toward food, substances, stimulation, anything that promises relief or pleasure. When this system is properly regulated, it functions as a compass. When it is dysregulated, it becomes a compulsion.

What the research is now making undeniably clear is that endocrine-disrupting chemicals — the EDCs hiding in your plastics, your personal care products, your canned foods, your receipts — are interfering with the precise neurochemistry that governs this state. And they are doing it at the level of the brain’s reward circuitry itself.

The Reward System Wasn’t Designed for This

The mesolimbic dopamine system is one of the most conserved and essential circuits in the human brain. Dopamine release in the nucleus accumbens drives motivation, anticipation, and approach behavior toward naturally rewarding stimuli — food, connection, and reproduction. Every substance of abuse, from cocaine to alcohol to nicotine, hijacks this same pathway, flooding the system with dopamine signals the brain was never designed to sustain.

But here is what most people are not being told: environmental chemicals are compromising this system long before a drug or compulsive behavior enters the picture.

Peer-reviewed literature has identified that endocrine disruptors such as bisphenol A (BPA) mimic estrogenic activity and directly impact dopaminergic processes, enhancing mesolimbic dopamine activity — producing hyperactivity, attention dysregulation, and what researchers describe as a heightened sensitivity to drugs of abuse. The hypothesis, now supported by animal self-administration studies, is that BPA exposure — particularly during early development — can increase vulnerability to addiction by priming the reward circuit into a state of chronic over-reactivity.

This is not a fringe theory. This is National Institutes of Health-funded research and published findings from institutions including the State University of New York, examining BPA exposure, gender, and cocaine seeking behavior.

The Hypothalamus Is Ground Zero

If you want to understand why EDCs matter so profoundly for cravings, appetite, and the appetitive state specifically, you have to understand the hypothalamus.

The hypothalamus is the brain’s master regulator of appetite, satiety, and motivated behavior. It houses the neural populations that signal to the body it is full, those that drive it to seek food when depleted, and those that modulate the entire hormonal cascade downstream. Two of its most powerful appetite-driving neuropeptides — AgRP and NPY — are orexigenic: they create hunger and sustain food-seeking behavior.

Research published in the International Journal of Molecular Sciences has documented that BPA directly stimulates the expression of these orexigenic neuropeptides, activating the very same appetite-driving machinery that, under normal conditions, is reserved for genuine states of biological need. Phthalate compounds show similar effects, with DEHP exposure linked to augmented hypothalamic neuropeptide expression and increased food intake.

Environmental estrogens — a category that includes BPA, phthalates, parabens, PCBs, and many pesticides — have also been shown to accelerate neurogenesis and neuronal migration in the developing hypothalamus, improperly programming the very neural architecture responsible for knowing when enough is enough.

This is not about eating too much. This is about a system that has been chemically taught never to feel like it has enough.

The Allostatic Cost No One Is Counting

In clinical practice, we speak of allostatic load — the cumulative physiological burden of chronic stress and dysregulation on the body’s adaptive systems. EDC exposure is an allostatic stressor, and it is one that accumulates silently across a lifetime.

The science shows us that BPA and phthalate exposures, even at doses below currently established safety thresholds, alter behavior, disrupt the hypothalamic-pituitary-gonadal-adrenal axis, interfere with thyroid hormone signaling, and produce lasting neurological changes. Some of these changes involve the very receptors — estrogen receptor beta, melanocortin receptors, oxytocin, and vasopressin signaling pathways — that regulate stress resilience, social bonding, and emotional regulation.

When we ask why someone cannot seem to get traction on their health — why they are reactive, craving-driven, exhausted, and still unable to feel settled in their own nervous system — we must start asking whether their biochemistry has been chemically repositioned into a state of chronic appetitive drive.

Not because they are broken. Because their environment has been systematically altering the neurochemical conditions that make regulation possible.

Epigenetics and the Inheritance of Dysregulation

Perhaps the most sobering dimension of this research is what it tells us about inheritance.

EDCs, even at low doses, have been documented to promote epigenetic transgenerational transmission of obesity, reproductive dysfunction, and metabolic dysregulation in subsequent generations — meaning the children and grandchildren of individuals exposed during critical developmental windows may carry the neurological and hormonal signatures of that exposure without ever having direct chemical contact themselves.

This is known as: epigenetic memory

We are not merely asking about an individual’s toxic burden. We are looking at a legacy of altered receptor sensitivity, dysregulated appetite signaling, and primed reward circuitry that spans generations.

This is the context in which we need to be having conversations about cravings, compulsivity, and the inability to feel like enough.

What This Means Clinically

If you work with clients who are struggling with cravings, compulsive eating, substance use, or the persistent sense that their appetite — for food, for stimulation, for relief — is running them rather than the other way around, the EDC question belongs in the intake conversation.

Not because it removes agency. Because it restores an accurate understanding.

When someone understands that their drive state has been chemically altered, that the “wanting” they feel is NOT a character flaw but a measurable disruption in hypothalamic neuropeptide expression and mesolimbic dopamine activity, the entire therapeutic conversation shifts. We are no longer talking about willpower. We are talking about empowerment and system restoration.

That is the work of Aromagenomics™️: meeting the biochemistry where it actually is, not where we wish it were.

The body has not forgotten how to regulate. In most cases, it has simply been operating in a chemically hostile environment without anyone naming it as such.

That is where we begin.

Download the comprehensive EDC Reference Table here

Tammy L. Davis is a Master Clinical Neuroaromatherapist, founder of Aromagenomics™️, and developer of the ANIS™ (Aromatic Neural Integration System)™️. She trains licensed healthcare professionals in evidence-based neuroaromatherapy and is the author of The Scent of Enough and a seven-book series titled: A Constituent-Based Guide to Essential Oils, with book 1 available now! .

Her ANIS™ Practitioner Intensives are hosted from Santa Fe, New Mexico.

References available upon request. Key literature includes:

• Schug et al. (2015). Elucidating the Links Between Endocrine Disruptors and Neurodevelopment. Endocrinology, 156(6).

• Vassilopoulou et al. (2024). The Role of Endocrine Disruptors in Obesity. Int J Mol Sci, 25(1).

• Ehsanifar et al. (2025). Mental Health Disorders Following Exposure to Endocrine Disruptor Chemicals. OBM Neurobiology, 9(2).

• SUNY Research Program: Addiction, Gender, and Endocrine Disruptors (Elsevier Pure).

• Environmental neurotoxicants and the dopaminergic system (PubMed PMID: 18555207).